Biolidics Ltd (BIOL)

Singapore
0.27
+0.005(+1.89%)
  • Volume:
    164,000
  • Bid/Ask:
    0.27/0.27
  • Day's Range:
    0.27 - 0.275

BIOL Overview

Prev. Close
0.265
Day's Range
0.27 - 0.275
Revenue
8.91M
Open
0.27
52 wk Range
0.265 - 0.58
EPS
-0.02
Volume
164,000
Market Cap
71.67M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
488,106
P/E Ratio
-
Beta
-
1-Year Change
-43.16%
Shares Outstanding
265,451,700
Next Earnings Date
-
What is your sentiment on Biolidics Ltd?
or
Market is currently closed. Voting is open during market hours.

Biolidics Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsBuyBuySellStrong SellSell
SummaryNeutralNeutralStrong SellStrong SellSell

Biolidics Ltd Company Profile

Biolidics Ltd Company Profile

Biolidics Ltd is a Singapore-based medial technology company that develops cell enrichment systems. The cell enrichment systems in combination with other analytical tests are used in applications that include cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company's product is ClearCell FX1 System, a fully automated cell enrichment medical device. It allows users to perform liquid biopsies to test for the presence of cancer cells and circulating tumor cells in blood samples and also perform further analysis on cancer cells.

Read More
  • * ENTERED DISTRIBUTION AGREEMENT TO APPOINT AYTU BIOSCIENCE AS EXCLUSIVE DISTRIBUTOR FOR CO'S RAPID TEST KITS FOR NOVEL CORONAVIRUS * AGREEMENT IS LIKELY TO CONTRIBUTE POSITIVELY TO REVENUE OF COMPANY FOR CURRENT FINANCIAL YEAR ENDING 31 DECEMBER 2020" REUTERS
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.